返回
P
Princess Margaret Cancer Centre
学者数175
论文数73
被引数4.0K
关联论文 (3220)
发表时间
MOCERTATUG REZETECAN (GSK5733584), A B7-H4-TARGETED ANTIBODY-DRUG CONJUGATE (ADC), IN PLATINUM-RESISTANT OVARIAN CANCER (PROC) AND ENDOMETRIAL CANCER (EC): FIRST RESULTS FROM THE GLOBAL BEHOLD-1 STUDYMOCERTATUG REZETECAN(GSK5733584),一种靶向B7-H4的抗体-药物偶联物(ADC),在铂耐药卵巢癌(PROC)和子宫内膜癌(EC)中的应用:全球BEHOLD-1研究初步结果

